ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

How to Ensure Surgical Head and Neck Clinical Trials Are Beneficial to Patients

by Renée Bacher • November 10, 2019

  • Tweet
  • Email
Print-Friendly Version
© SergeyBitos / shutterstock.com

© SergeyBitos / shutterstock.com

Randomized controlled trials can take a great deal of time, money, and effort. Hisham Mehanna, MD, chair of head and neck surgery at the Institute of Cancer and Genomic Sciences and director of the Institute of Head and Neck Studies and Education at the School of Cancer Sciences at the University of Birmingham in the U.K., wondered about their return on investment for patients with head and neck cancer and the healthcare systems that serve them.

You Might Also Like

  • Post-Treatment Persistence of Oral HPV in Head and Neck Cancer Predicts Recurrence, Death
  • Surgical Therapy for Pediatric Patients with NTM Head and Neck Lesions Carries High Risk
  • Randomized Trials in Head Neck are Statistically Nonrobust
  • Why Sex Bias Occurs in Clinical Trials and How We Can Change It
Explore This Issue
November 2019

In his Eugene N. Myers, MD International Lecture on Head and Neck Cancer, “What Have Head and Neck Clinical Trials Ever Done for Our Patients Anyway?” Dr. Mehanna covered the benefits and flaws in clinical trials in head and neck cancer over the past two decades.

He referenced the presidential address delivered by John Andrew Ridge, MD, PhD, at the 2010 American Head and Neck Society meeting, which spoke of medical oncologists and clinical radiologists having a history of participating in clinical trials, whereas surgical oncologists did not. In the decade preceding
2010, surgical oncologists had not conducted a single clinical trial, and Dr. Ridge asserted that surgeons were willing to change their practice without Level 1 evidence. “Dr. Ridge believed surgeons had been dismissed as an intellectual force, even by surgeons themselves,” Dr. Mehanna said.

In the aftermath of Dr. Ridge’s address, surgeons led four major head and neck trials between 2011 and 2019. “Things have changed,” Dr. Mehanna said. “I think this reflects the rise of the head and neck surgeon–scientist.”

The Last 10 Years

Here are the four major clinical trials in head and neck cancer led by surgeons over the past decade and their results:

  1. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. Led by Anil D’Cruz, MD, in Mumbai and also known as the Tata Trial because it was run by the Tata Memorial Centre, this
    trial concluded that, among patients with early-stage oral squamous-cell cancer, elective neck dissection resulted in higher rates of overall and disease-free survival than therapeutic neck dissection (N Engl J Med. 2015;373:521–529).
  2. PET-NECK. This multicenter randomized phase III non-inferiority trial compared a PET-CT–guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Led by Dr. Mehanna, the trial concluded that PET-CT–guided active surveillance showed similar survival outcomes with planned neck dissection but resulted in considerably fewer planned neck dissections, fewer complications, and lower costs, supporting its use in routine practice (N Engl J Med. 2016;374:1444–1454).
  3. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. Led by Bob Ferris, MD in Pittsburgh, this trial concluded that, among patients with platinum-refractory, recurrent squamous-cell carcinoma of the head and neck, treatment with nivolumab resulted in longer overall survival than treatment with standard, single-
    agent therapy (N Engl J Med. 2016;375:1856–1867).
  4. De-ESCALaTE HPV. This open-label randomized controlled phase 3 trial looked at radiotherapy plus cisplatin or cetuximab in low-risk HPV-positive oropharyngeal cancer. Also led by Dr. Mehanna, this trial’s interpretation was that cetuximab, compared with the standard cisplatin regimen, showed no benefit in terms of reduced toxicity, but instead showed significant detriment in terms of tumor control. It advised that cisplatin and radiotherapy should be used as the standard of care for HPV-positive low-risk patients who are able to tolerate cisplatin (Lancet. 2019;393:51–60).

Design Flaws

Dr. Mehanna said there are issues that come up regularly in surgical research that are important to consider carefully. Clinical trials are a good way of addressing these pitfalls. They include:

Pages: 1 2 3 | Single Page

Filed Under: Features Tagged With: AAO-HNS 2019, clinical research, clinical trials, head and neck cancerIssue: November 2019

You Might Also Like:

  • Post-Treatment Persistence of Oral HPV in Head and Neck Cancer Predicts Recurrence, Death
  • Surgical Therapy for Pediatric Patients with NTM Head and Neck Lesions Carries High Risk
  • Randomized Trials in Head Neck are Statistically Nonrobust
  • Why Sex Bias Occurs in Clinical Trials and How We Can Change It

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Why Virtual Grand Rounds May Be Here to Stay
    • Otolaryngologist Leverages His Love of Pinball into Second Business
    • These New Imaging Advances May Help to Protect Parathyroids
    • Is the Training and Cost of a Fellowship Worth It? Here’s What Otolaryngologists Say
    • Which Otologic Procedures Poses the Greatest Risk of Aerosol Generation?

Polls

Have you used 3D-printed materials in your otolaryngology practice?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.